People are taking an unapproved weight-loss drug. AI found something surprising
An experimental weight-loss drug that has not yet received regulatory approval is already attracting users willing to obtain…
Telehealth sees rising off-label use of GLP-1s for substance abuse
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition
Around half a million Australians use GLP-1 medications for diabetes – and when you add people who use…
Misuse of life-saving meds for drug abuse will not be allowed, says Punjab health minister – The Times of India
Misuse of life-saving meds for drug abuse will not be allowed, says Punjab health minister The Times of IndiaPunjab…
Beauty Brands Target ‘Ozempic Face’ Market Amid Obesity Drug Surge, ETRetail
Swiss skincare firm Galderma, Brazilian cosmetics group Natura and beauty giant L’Oreal are testing treatments for consumers worried…
GLP-1 drug distributed nationwide under recall
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.…
We bought and tested what was sold as an experimental weight loss drug. The lab results were “pretty terrifying.”
A drug that’s not FDA approved and still in clinical trials is being advertised all over the internet.…
FDA recalls GLP-1 drug, other injectable medication over sterility concerns
article A woman holds a slimming syringe from Eli Lilly with the name Mounjaro and the active ingredient…
Taking medicines for a chronic condition? 8 ways to avoid common treatment mistakes
Living with a chronic condition means medicines become part of daily life for years, and often for life.…
Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market | Consumer
By Richa Naidu, Dominique Patton and Alexander Marrow LONDON/PARIS, Oct 21 (Reuters) – Swiss skincare firm Galderma, Brazilian…
TGA recalls common cold and flu ingredient over anaphylaxis risk
A herb found in dozens of complementary cold and flu supplements will no longer be classified as a…
CVS to pay $315 million for illegally filling unlawful opioid prescriptions, submitting false claims : Big Island Now
Rhode Island-based pharmacy chain CVS Pharmacy Inc. and its related corporate entities, including Longs Drugs, will pay $315…